Phase 2 trial in 198 adults with uncontrolled hypertension on 2-5 drugs: monthly tonlamarsen cut plasma angiotensinogen more than a single dose then placebo (-67.2% vs -23.0%), but office systolic BP fell equally (-6.7 vs -6.7 mm Hg; P=0.97).
RCTn = 198
Laffin et al. Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial